These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26279755)

  • 21. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
    Gangadharan Komala M; Gross S; Mudaliar H; Huang C; Pegg K; Mather A; Shen S; Pollock CA; Panchapakesan U
    PLoS One; 2014; 9(11):e108994. PubMed ID: 25369239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of centella asiatica granule on the expression of TGF-β
    Ma JW; Wang HT; Liu HF; Ding Y; Bai JQ; Zhang Z
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):69-73. PubMed ID: 29926663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis.
    Ho C; Lee PH; Hsu YC; Wang FS; Huang YT; Lin CL
    Am J Med Sci; 2012 Nov; 344(5):374-82. PubMed ID: 22270399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
    Alter ML; Ott IM; von Websky K; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Klein T; Hocher B
    Kidney Blood Press Res; 2012; 36(1):119-30. PubMed ID: 23171828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.
    Kosugi T; Yuzawa Y; Sato W; Kawai H; Matsuo S; Takei Y; Muramatsu T; Kadomatsu K
    Am J Pathol; 2006 Jan; 168(1):9-19. PubMed ID: 16400005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
    Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
    Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?
    Halici Z; Bilen H; Albayrak F; Uyanik A; Cetinkaya R; Suleyman H; Keles ON; Unal B
    Eur J Pharmacol; 2009 Jul; 614(1-3):146-52. PubMed ID: 19406119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renal TGF-beta system in the db/db mouse model of diabetic nephropathy.
    Cohen MP; Sharma K; Guo J; Eltayeb BO; Ziyadeh FN
    Exp Nephrol; 1998; 6(3):226-33. PubMed ID: 9639038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension accelerates diabetic nephropathy in Wistar fatty rats, a model of type 2 diabetes mellitus, via mitogen-activated protein kinase cascades and transforming growth factor-beta1.
    Imai G; Satoh T; Kumai T; Murao M; Tsuchida H; Shima Y; Ogimoto G; Fujino T; Kobayashi S; Kimura K
    Hypertens Res; 2003 Apr; 26(4):339-47. PubMed ID: 12733703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
    Lang H; Dai C
    Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
    Chaudagar KK; Mehta AA
    Clin Exp Hypertens; 2014; 36(8):557-66. PubMed ID: 24490705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of calcitriol on diabetic nephropathy are mediated by down regulation of TGF-β1 and CIP4 in diabetic nephropathy rat.
    Yu R; Mao J; Yang Y; Zhang Y; Tian Y; Zhu J
    Int J Clin Exp Pathol; 2015; 8(4):3503-12. PubMed ID: 26097534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
    Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
    Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice.
    Ohara I; Tanimoto M; Gohda T; Yamazaki T; Hagiwara S; Murakoshi M; Aoki T; Toyoda H; Ishikawa Y; Funabiki K; Horikoshi S; Tomino Y
    Nephron Exp Nephrol; 2011; 117(4):e124-32. PubMed ID: 20948237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of vascular endothelial growth factor in diabetic nephropathy.
    Cha DR; Kim NH; Yoon JW; Jo SK; Cho WY; Kim HK; Won NH
    Kidney Int Suppl; 2000 Sep; 77():S104-12. PubMed ID: 10997699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats.
    Furuse Y; Hashimoto N; Maekawa M; Toyama Y; Nakao A; Iwamoto I; Sakurai K; Suzuki Y; Yagui K; Yuasa S; Toshimori K; Saito Y
    Nephron Exp Nephrol; 2004; 98(3):e100-8. PubMed ID: 15528945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal endothelial protein C receptor expression and shedding during diabetic nephropathy.
    Lattenist L; Ochodnický P; Ahdi M; Claessen N; Leemans JC; Satchell SC; Florquin S; Gerdes VE; Roelofs JJ
    J Thromb Haemost; 2016 Jun; 14(6):1171-82. PubMed ID: 26990852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
    Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
    Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.